Skip to content
Advertisement

FILE - Secretary of Health and Human Services Xavier Becerra testifies before a Senate Health, Education, Labor, and Pensions Committee hearing, Sept. 30, 2021 on Capitol Hill in Washington. U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year. The increase was largely attributed to a pricey new Alzheimer’s drug with questionable benefits. Becerra’s directive on Monday comes days after drugmaker Biogen slashed the price of its $56,000-a-year medication, Aduhelm, to $28,200 a year — a cut of about half. (Shawn Thew/Pool via AP, File)

FILE - Secretary of Health and Human Services Xavier Becerra testifies before a Senate Health, Education, Labor, and Pensions Committee hearing, Sept. 30, 2021 on Capitol Hill in Washington. U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year. The increase was largely attributed to a pricey new Alzheimer’s drug with questionable benefits. Becerra’s directive on Monday comes days after drugmaker Biogen slashed the price of its $56,000-a-year medication, Aduhelm, to $28,200 a year — a cut of about half. (Shawn Thew/Pool via AP, File)

Featured Photo Galleries